Skip to main content

Stemolecule™ PD0325901

04-0006 / 04-0006-10 / 04-0006-02

Brand: Stemolecule™

PD03225901 inhibits mitogen-activated protein kinase (MAPK/ERK kinase or MEK) and demonstrates potential antineoplastic activity.

CAS Number: 391210-10-9
Alternate Name(s):
  • N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
Stemolecule™ PD0325901

Currency: 

Product name Catalog number Pack size Price Price (USD) Price (GBP) Price (EUR)
Stemolecule™ PD0325901 (2 mg) 04-0006 2 mg (select above) $ 276.00 £ 227.00 € 266.00
Stemolecule™ PD0325901 (10 mg) 04-0006-10 10 mg (select above) $ 1081.00 £ 885.00 € 1034.00
Stemolecule™ PD0325901 (2 mg in solution (10 mM)) 04-0006-02 2 mg in solution (10 mM) (select above) $ 324.00 £ 266.00 € 311.00

USA Store

Note: prices shown do not include shipping and handling charges.

Product Information

PD0325901 is a small molecule targeting mitogen-activated protein kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. PD0325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation1,2. Along with the ALK5 inhibitor SB431542, PD0325901 has also been shown to increase the efficiency of reprogramming human primary fibroblasts into induced pluripotent stem (iPS) cells3.

Stemolecule PD0325901 is also available as a 10 mM DMSO Stock Solution in DMSO (2 mg in 414.8 μl) (Cat. No. 04-0006-02).


stemgent-logo-small

Stemgent and the Stemolecule brand name are trademarks of REPROCELL Inc., Japan.